Efficacy of Continuous Erector Spinae Plane Block to Reduce Postoperative Pain in Patients Undergoing Unilateral Thoracotomy

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21-65
SponsorUdayana University

About this trial

The goal of this clinical trial is to learn if continuous Erector Spinae Plane Block (ESPB) reduces postoperative pain in patients undergoing unilateral thoracotomy. It will also evaluate the safety and effectiveness of continuous ESPB. The total participants needed will be 30 persons. The main questions it aims to answer are:

* Does continuous ESPB lower the intensity of postoperative pain compared to multimodal intravenous analgesia? * Does continuous ESPB increase the time to first analgesic request? * Does continuous ESPB reduce the amount of intravenous opioids required in the first 48 hours after surgery? * Does continuous ESPB improve the overall recovery quality within 48 hours post-surgery?

Participants will:

* Receive continuous ESPB or multimodal intravenous analgesia after the surgery. * Undergo routine pain assessments, and recovery evaluations using tools like the Visual Analogue Scale (VAS) and Quality of Recovery-15 (QoR-15). * Participate in follow-up visits for data collection on pain, opioid usage, and recovery quality.

Eligibility criteria

Qualifiers

Patients of 21-65 years of age

Undergoing Unilateral Thoracotomy Operation

Disqualifiers

Patients with ASA Physical Status > III

Obese or Underweight Patients with BMI of less than 18.5 or more than 29.99

Patients with contraindications to be given local anesthesia drugs

Patients with contraindications to be given opioid drugs

Trial design

Treatments tested in this trial

  • Continuous Erector Spinae Plane Block
  • Multimodal Intravenous Analgesia

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators